Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)

Condition:   Squamous Cell Carcinoma of the Head and Neck
Interventions:   Drug: Avelumab;   Other: Chemoradiation
Sponsor:   Pfizer
Not yet recruiting - verified October 2016

http://ift.tt/2eUO15U